<--- Back to Details
First PageDocument Content
HLA-A / Human leukocyte antigen / HLA-DR / HLA-DR12 / HLA-DR11 / Biology / MHC Class II / Immune system
Date: 2012-04-14 16:11:51
HLA-A
Human leukocyte antigen
HLA-DR
HLA-DR12
HLA-DR11
Biology
MHC Class II
Immune system

Test Request Form 640 Ellicott Street, Buffalo, NY[removed]Phone[removed] • Fax[removed]IMMUNOGENETICS LABORATORY HSC/BM Services

Add to Reading List

Source URL: immco.com

Download Document from Source Website

File Size: 103,76 KB

Share Document on Facebook

Similar Documents

Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis Jenny Link1., Malin Lundkvist Ryner1*., Katharina Fink1, Christina Herma

Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis Jenny Link1., Malin Lundkvist Ryner1*., Katharina Fink1, Christina Herma

DocID: 1tQgK - View Document

FOR IMMEDIATE RELEASE  ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company

FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company

DocID: 1r0rg - View Document

Inland Northwest Blood Center

Inland Northwest Blood Center

DocID: 1qGf9 - View Document

DE  Information: Gebrauchsinformation Mastermixe/Magnesiumchlorid für HISTO SPOT® SSO Kits Testkits zur Typisierung von HLA Allelen auf molekulargenetischer Basis

DE Information: Gebrauchsinformation Mastermixe/Magnesiumchlorid für HISTO SPOT® SSO Kits Testkits zur Typisierung von HLA Allelen auf molekulargenetischer Basis

DocID: 1pYNI - View Document

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1pYBv - View Document